Previous Article | Next Article 
J Virol, March 1998, p. 2406-2415, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Delayed Infection after Immunization with a Peptide
from the Transmembrane Glycoprotein of the Feline
Immunodeficiency Virus
J.
Richardson,1
A.
Moraillon,2
F.
Crespeau,3
S.
Baud,1
P.
Sonigo,1,* and
G.
Pancino1
Génétique des Virus (ICGM-CNRS
UPR 0415), Institut Cochin de Génétique Moléculaire,
75014 Paris,1 and
Génétique
moléculaire génétique virale
(INRA)2 and
Pathologie Cellulaire et
Moléculaire (URA-INRA),3 Ecole
Nationale Vétérinaire d'Alfort, 94704 Maisons-Alfort
Cedex, France
Received 30 July 1997/Accepted 20 November 1997
Recent advances in the quantitative assessment of viral burden, by
permitting the extension of criteria applied to assess the efficacy of
vaccines from all-or-none protection to diminution of the viral burden,
may allow the identification of original immunogens of value in
combined vaccines. Peptides corresponding to three domains of the
envelope glycoproteins of feline immunodeficiency virus that are
recognized during natural infection were used to immunize cats. After
challenge with a primary isolate of feline immunodeficiency virus, the
development of acute infection was monitored by quantitative assessment
of the viral burden in plasma and tissues by competitive reverse
transcription-PCR, by measurement of the humoral response developed to
viral components, and by lymphocyte subset analysis. Whereas
immunization with two peptides derived from the surface glycoprotein
had no effect on the early course of infection, immunization with a
peptide derived from the transmembrane glycoprotein delayed infection,
as reflected by a diminished viral burden in the early phase of primary
infection and delayed seroconversion. This peptide, located in the
membrane-proximal region of the extracellular domain, has homology to
an epitope of human immunodeficiency virus type 1 recognized by a
broadly neutralizing monoclonal antibody. These results suggest that
lentivirus transmembrane glycoproteins share a determinant in the
juxtamembrane ectodomain which could be of importance in the design of
vaccines against AIDS.
*
Corresponding author. Mailing address: Institut Cochin
de Génétique Moléculaire, Génétique des
Virus, 22, rue Méchain, 75014 Paris, France. Phone: (33)-(1)-40
51 64 15. Fax: (33)-(1)-40 51 72 10. E-mail:
sonigo{at}cochin.inserm.fr.
This article has been cited by other articles:
-
Giannecchini, S., D'Ursi, A. M., Esposito, C., Scrima, M., Zabogli, E., Freer, G., Rovero, P., Bendinelli, M.
(2007). Antibodies Generated in Cats by a Lipopeptide Reproducing the Membrane-Proximal External Region of the Feline Immunodeficiency Virus Transmembrane Enhance Virus Infectivity. CVI
14: 944-951
[Abstract]
[Full Text]
-
Broche-Pierre, S., Richardson, J., Moraillon, A., Sonigo, P.
(2005). Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties. J. Gen. Virol.
86: 2495-2506
[Abstract]
[Full Text]
-
Huisman, W., Schrauwen, E. J. A., Pas, S. D., Karlas, J. A., Rimmelzwaan, G. F., Osterhaus, A. D. M. E.
(2004). Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats. J. Gen. Virol.
85: 1833-1841
[Abstract]
[Full Text]
-
Giannecchini, S., Di Fenza, A., D'Ursi, A. M., Matteucci, D., Rovero, P., Bendinelli, M.
(2003). Antiviral Activity and Conformational Features of an Octapeptide Derived from the Membrane-Proximal Ectodomain of the Feline Immunodeficiency Virus Transmembrane Glycoprotein. J. Virol.
77: 3724-3733
[Abstract]
[Full Text]
-
Richardson, J., Broche, S., Baud, S., Leste-Lasserre, T., Femenia, F., Levy, D., Moraillon, A., Pancino, G., Sonigo, P.
(2002). Lymphoid activation: a confounding factor in AIDS vaccine development?. J. Gen. Virol.
83: 2515-2521
[Abstract]
[Full Text]
-
Goto, Y., Nishimura, Y., Baba, K., Mizuno, T., Endo, Y., Masuda, K., Ohno, K., Tsujimoto, H.
(2002). Association of Plasma Viral RNA Load with Prognosis in Cats Naturally Infected with Feline Immunodeficiency Virus. J. Virol.
76: 10079-10083
[Abstract]
[Full Text]
-
Bendinelli, M., Pistello, M., Del Mauro, D., Cammarota, G., Maggi, F., Leonildi, A., Giannecchini, S., Bergamini, C., Matteucci, D.
(2001). During Readaptation In Vivo, a Tissue Culture-Adapted Strain of Feline Immunodeficiency Virus Reverts to Broad Neutralization Resistance at Different Times in Individual Hosts but through Changes at the Same Position of the Surface Glycoprotein. J. Virol.
75: 4584-4593
[Abstract]
[Full Text]
-
Bertoni, G., Hertig, C., Zahno, M.-L., Vogt, H.-R., Dufour, S., Cordano, P., Peterhans, E., Cheevers, W. P., Sonigo, P., Pancino, G.
(2000). B-cell epitopes of the envelope glycoprotein of caprine arthritis-encephalitis virus and antibody response in infected goats. J. Gen. Virol.
81: 2929-2940
[Abstract]
[Full Text]
-
Lerner, D. L., Elder, J. H.
(2000). Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin-2-Independent T Cells. J. Virol.
74: 1854-1863
[Abstract]
[Full Text]
-
Pistello, M., Matteucci, D., Cammarota, G., Mazzetti, P., Giannecchini, S., Del Mauro, D., Macchi, S., Zaccaro, L., Bendinelli, M.
(1999). Kinetics of Replication of a Partially Attenuated Virus and of the Challenge Virus during a Three-Year Intersubtype Feline Immunodeficiency Virus Superinfection Experiment in Cats. J. Virol.
73: 1518-1527
[Abstract]
[Full Text]
-
Mazzetti, P., Giannecchini, S., Del Mauro, D., Matteucci, D., Portincasa, P., Merico, A., Chezzi, C., Bendinelli, M.
(1999). AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Detailed Analysis of the Humoral Immune Response to a Protective Vaccine. J. Virol.
73: 1-10
[Abstract]
[Full Text]